nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—SLCO1A2—Chlorambucil—ovarian cancer	0.133	0.165	CbGbCtD
Rosuvastatin—SLCO1B3—Paclitaxel—ovarian cancer	0.0739	0.0919	CbGbCtD
Rosuvastatin—ABCB11—Paclitaxel—ovarian cancer	0.0719	0.0894	CbGbCtD
Rosuvastatin—ABCG2—Topotecan—ovarian cancer	0.069	0.0859	CbGbCtD
Rosuvastatin—SLCO1B3—Docetaxel—ovarian cancer	0.0534	0.0664	CbGbCtD
Rosuvastatin—ABCC1—Epirubicin—ovarian cancer	0.0518	0.0644	CbGbCtD
Rosuvastatin—ABCC1—Paclitaxel—ovarian cancer	0.0511	0.0635	CbGbCtD
Rosuvastatin—ABCB11—Doxorubicin—ovarian cancer	0.0387	0.0482	CbGbCtD
Rosuvastatin—ABCC1—Docetaxel—ovarian cancer	0.0369	0.0459	CbGbCtD
Rosuvastatin—ABCG2—Paclitaxel—ovarian cancer	0.0342	0.0425	CbGbCtD
Rosuvastatin—ABCG2—Carboplatin—ovarian cancer	0.0322	0.04	CbGbCtD
Rosuvastatin—ABCC1—Doxorubicin—ovarian cancer	0.0275	0.0342	CbGbCtD
Rosuvastatin—ABCG2—Docetaxel—ovarian cancer	0.0247	0.0307	CbGbCtD
Rosuvastatin—CYP3A5—Paclitaxel—ovarian cancer	0.0189	0.0236	CbGbCtD
Rosuvastatin—ABCG2—Doxorubicin—ovarian cancer	0.0184	0.0229	CbGbCtD
Rosuvastatin—CYP3A4—Topotecan—ovarian cancer	0.0149	0.0186	CbGbCtD
Rosuvastatin—CYP3A5—Docetaxel—ovarian cancer	0.0137	0.017	CbGbCtD
Rosuvastatin—CYP2C9—Paclitaxel—ovarian cancer	0.0127	0.0158	CbGbCtD
Rosuvastatin—CYP3A4—Vinorelbine—ovarian cancer	0.0105	0.0131	CbGbCtD
Rosuvastatin—CYP3A4—Paclitaxel—ovarian cancer	0.00738	0.00919	CbGbCtD
Rosuvastatin—CYP3A4—Docetaxel—ovarian cancer	0.00534	0.00664	CbGbCtD
Rosuvastatin—CYP3A4—Doxorubicin—ovarian cancer	0.00398	0.00495	CbGbCtD
Rosuvastatin—HMGCR—myometrium—ovarian cancer	0.00168	0.0359	CbGeAlD
Rosuvastatin—SLC7A11—female reproductive system—ovarian cancer	0.00158	0.0337	CbGeAlD
Rosuvastatin—SLCO1B3—vagina—ovarian cancer	0.00147	0.0314	CbGeAlD
Rosuvastatin—SLC7A11—female gonad—ovarian cancer	0.00144	0.0306	CbGeAlD
Rosuvastatin—HMGCR—epithelium—ovarian cancer	0.00132	0.0282	CbGeAlD
Rosuvastatin—HMGCR—uterine cervix—ovarian cancer	0.00131	0.0279	CbGeAlD
Rosuvastatin—SLC7A11—testis—ovarian cancer	0.00127	0.0272	CbGeAlD
Rosuvastatin—HMGCR—decidua—ovarian cancer	0.00125	0.0266	CbGeAlD
Rosuvastatin—HMGCR—endometrium—ovarian cancer	0.00118	0.0253	CbGeAlD
Rosuvastatin—ABCB11—testis—ovarian cancer	0.00113	0.0241	CbGeAlD
Rosuvastatin—HMGCR—gonad—ovarian cancer	0.0011	0.0234	CbGeAlD
Rosuvastatin—HMGCR—uterus—ovarian cancer	0.00109	0.0233	CbGeAlD
Rosuvastatin—ABCC1—myometrium—ovarian cancer	0.00108	0.023	CbGeAlD
Rosuvastatin—SLCO2B1—decidua—ovarian cancer	0.00106	0.0226	CbGeAlD
Rosuvastatin—HMGCR—female reproductive system—ovarian cancer	0.000981	0.0209	CbGeAlD
Rosuvastatin—SLCO1B1—female reproductive system—ovarian cancer	0.00094	0.0201	CbGeAlD
Rosuvastatin—HMGCR—bone marrow—ovarian cancer	0.000926	0.0198	CbGeAlD
Rosuvastatin—SLCO2B1—uterus—ovarian cancer	0.000925	0.0197	CbGeAlD
Rosuvastatin—HMGCR—female gonad—ovarian cancer	0.000893	0.0191	CbGeAlD
Rosuvastatin—ABCG2—myometrium—ovarian cancer	0.000891	0.019	CbGeAlD
Rosuvastatin—HMGCR—vagina—ovarian cancer	0.000887	0.0189	CbGeAlD
Rosuvastatin—ABCC1—uterine cervix—ovarian cancer	0.000838	0.0179	CbGeAlD
Rosuvastatin—SLCO2B1—female reproductive system—ovarian cancer	0.000831	0.0177	CbGeAlD
Rosuvastatin—ABCC4—uterus—ovarian cancer	0.000819	0.0175	CbGeAlD
Rosuvastatin—ABCC1—decidua—ovarian cancer	0.000798	0.017	CbGeAlD
Rosuvastatin—HMGCR—testis—ovarian cancer	0.000792	0.0169	CbGeAlD
Rosuvastatin—ABCC1—endometrium—ovarian cancer	0.000758	0.0162	CbGeAlD
Rosuvastatin—SLCO2B1—female gonad—ovarian cancer	0.000756	0.0161	CbGeAlD
Rosuvastatin—ABCC4—female reproductive system—ovarian cancer	0.000736	0.0157	CbGeAlD
Rosuvastatin—ABCC1—uterus—ovarian cancer	0.000698	0.0149	CbGeAlD
Rosuvastatin—ABCC4—bone marrow—ovarian cancer	0.000695	0.0148	CbGeAlD
Rosuvastatin—ABCG2—uterine cervix—ovarian cancer	0.000694	0.0148	CbGeAlD
Rosuvastatin—SLCO2B1—testis—ovarian cancer	0.000671	0.0143	CbGeAlD
Rosuvastatin—ABCC4—female gonad—ovarian cancer	0.00067	0.0143	CbGeAlD
Rosuvastatin—ABCG2—decidua—ovarian cancer	0.000661	0.0141	CbGeAlD
Rosuvastatin—CYP3A5—uterine cervix—ovarian cancer	0.000644	0.0137	CbGeAlD
Rosuvastatin—ABCG2—endometrium—ovarian cancer	0.000627	0.0134	CbGeAlD
Rosuvastatin—SLCO1A2—testis—ovarian cancer	0.000617	0.0132	CbGeAlD
Rosuvastatin—ALB—testis—ovarian cancer	0.000614	0.0131	CbGeAlD
Rosuvastatin—ABCC4—testis—ovarian cancer	0.000594	0.0127	CbGeAlD
Rosuvastatin—ABCG2—uterus—ovarian cancer	0.000578	0.0123	CbGeAlD
Rosuvastatin—HMGCR—lymph node—ovarian cancer	0.000574	0.0122	CbGeAlD
Rosuvastatin—ABCC1—female gonad—ovarian cancer	0.000571	0.0122	CbGeAlD
Rosuvastatin—ABCC1—vagina—ovarian cancer	0.000568	0.0121	CbGeAlD
Rosuvastatin—CYP2C19—vagina—ovarian cancer	0.000554	0.0118	CbGeAlD
Rosuvastatin—ABCC1—testis—ovarian cancer	0.000507	0.0108	CbGeAlD
Rosuvastatin—ABCG2—bone marrow—ovarian cancer	0.000491	0.0105	CbGeAlD
Rosuvastatin—SLCO2B1—lymph node—ovarian cancer	0.000486	0.0104	CbGeAlD
Rosuvastatin—Arrhythmia—Vinorelbine—ovarian cancer	0.000475	0.00485	CcSEcCtD
Rosuvastatin—CYP2C9—female reproductive system—ovarian cancer	0.000475	0.0101	CbGeAlD
Rosuvastatin—ABCG2—female gonad—ovarian cancer	0.000473	0.0101	CbGeAlD
Rosuvastatin—Cough—Topotecan—ovarian cancer	0.000472	0.00482	CcSEcCtD
Rosuvastatin—ABCG2—vagina—ovarian cancer	0.00047	0.01	CbGeAlD
Rosuvastatin—Breast disorder—Paclitaxel—ovarian cancer	0.000467	0.00477	CcSEcCtD
Rosuvastatin—Cough—Melphalan—ovarian cancer	0.000463	0.00472	CcSEcCtD
Rosuvastatin—Myalgia—Topotecan—ovarian cancer	0.000461	0.0047	CcSEcCtD
Rosuvastatin—Arthralgia—Topotecan—ovarian cancer	0.000461	0.0047	CcSEcCtD
Rosuvastatin—Muscular weakness—Paclitaxel—ovarian cancer	0.000456	0.00465	CcSEcCtD
Rosuvastatin—Blood disorder—Doxorubicin—ovarian cancer	0.000451	0.0046	CcSEcCtD
Rosuvastatin—Myalgia—Melphalan—ovarian cancer	0.000451	0.0046	CcSEcCtD
Rosuvastatin—Influenza—Paclitaxel—ovarian cancer	0.000447	0.00456	CcSEcCtD
Rosuvastatin—Cough increased—Epirubicin—ovarian cancer	0.000445	0.00454	CcSEcCtD
Rosuvastatin—ALB—lymph node—ovarian cancer	0.000445	0.00949	CbGeAlD
Rosuvastatin—CYP3A5—female gonad—ovarian cancer	0.000439	0.00937	CbGeAlD
Rosuvastatin—Infection—Topotecan—ovarian cancer	0.000439	0.00448	CcSEcCtD
Rosuvastatin—Pancreatitis—Paclitaxel—ovarian cancer	0.000438	0.00447	CcSEcCtD
Rosuvastatin—Dyspepsia—Chlorambucil—ovarian cancer	0.000437	0.00445	CcSEcCtD
Rosuvastatin—CYP3A5—vagina—ovarian cancer	0.000436	0.00931	CbGeAlD
Rosuvastatin—Nervous system disorder—Topotecan—ovarian cancer	0.000433	0.00442	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Topotecan—ovarian cancer	0.000433	0.00441	CcSEcCtD
Rosuvastatin—ABCC4—lymph node—ovarian cancer	0.000431	0.00919	CbGeAlD
Rosuvastatin—Bronchitis—Paclitaxel—ovarian cancer	0.00043	0.00438	CcSEcCtD
Rosuvastatin—Infection—Melphalan—ovarian cancer	0.00043	0.00438	CcSEcCtD
Rosuvastatin—Pain—Chlorambucil—ovarian cancer	0.000424	0.00433	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Melphalan—ovarian cancer	0.000424	0.00432	CcSEcCtD
Rosuvastatin—Angioedema—Vinorelbine—ovarian cancer	0.000423	0.00431	CcSEcCtD
Rosuvastatin—ABCG2—testis—ovarian cancer	0.000419	0.00895	CbGeAlD
Rosuvastatin—Cough increased—Doxorubicin—ovarian cancer	0.000412	0.0042	CcSEcCtD
Rosuvastatin—Feeling abnormal—Chlorambucil—ovarian cancer	0.000409	0.00417	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000406	0.00414	CcSEcCtD
Rosuvastatin—Cough—Vinorelbine—ovarian cancer	0.000404	0.00412	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000402	0.0041	CcSEcCtD
Rosuvastatin—Depression—Paclitaxel—ovarian cancer	0.000397	0.00405	CcSEcCtD
Rosuvastatin—Paraesthesia—Topotecan—ovarian cancer	0.000397	0.00405	CcSEcCtD
Rosuvastatin—Breast disorder—Docetaxel—ovarian cancer	0.000396	0.00404	CcSEcCtD
Rosuvastatin—Urticaria—Chlorambucil—ovarian cancer	0.000394	0.00402	CcSEcCtD
Rosuvastatin—Myalgia—Vinorelbine—ovarian cancer	0.000394	0.00402	CcSEcCtD
Rosuvastatin—Arthralgia—Vinorelbine—ovarian cancer	0.000394	0.00402	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000394	0.00402	CcSEcCtD
Rosuvastatin—Abdominal pain—Chlorambucil—ovarian cancer	0.000392	0.004	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.000391	0.00398	CcSEcCtD
Rosuvastatin—Dyspepsia—Topotecan—ovarian cancer	0.000389	0.00397	CcSEcCtD
Rosuvastatin—Paraesthesia—Melphalan—ovarian cancer	0.000388	0.00396	CcSEcCtD
Rosuvastatin—Urinary tract infection—Paclitaxel—ovarian cancer	0.000387	0.00395	CcSEcCtD
Rosuvastatin—Dyspepsia—Melphalan—ovarian cancer	0.000381	0.00388	CcSEcCtD
Rosuvastatin—Haematuria—Paclitaxel—ovarian cancer	0.00038	0.00388	CcSEcCtD
Rosuvastatin—Pain—Topotecan—ovarian cancer	0.000378	0.00385	CcSEcCtD
Rosuvastatin—Constipation—Topotecan—ovarian cancer	0.000378	0.00385	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000377	0.00384	CcSEcCtD
Rosuvastatin—Infection—Vinorelbine—ovarian cancer	0.000375	0.00383	CcSEcCtD
Rosuvastatin—Sinusitis—Paclitaxel—ovarian cancer	0.000374	0.00381	CcSEcCtD
Rosuvastatin—Nervous system disorder—Vinorelbine—ovarian cancer	0.000371	0.00378	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00037	0.00377	CcSEcCtD
Rosuvastatin—Pain—Melphalan—ovarian cancer	0.00037	0.00377	CcSEcCtD
Rosuvastatin—ABCC1—lymph node—ovarian cancer	0.000367	0.00784	CbGeAlD
Rosuvastatin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000366	0.00373	CcSEcCtD
Rosuvastatin—Feeling abnormal—Topotecan—ovarian cancer	0.000364	0.00371	CcSEcCtD
Rosuvastatin—CYP3A4—female reproductive system—ovarian cancer	0.000362	0.00773	CbGeAlD
Rosuvastatin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000361	0.00368	CcSEcCtD
Rosuvastatin—Rhinitis—Paclitaxel—ovarian cancer	0.000359	0.00366	CcSEcCtD
Rosuvastatin—Hypertonia—Epirubicin—ovarian cancer	0.000357	0.00364	CcSEcCtD
Rosuvastatin—Asthenia—Chlorambucil—ovarian cancer	0.000356	0.00363	CcSEcCtD
Rosuvastatin—Pharyngitis—Paclitaxel—ovarian cancer	0.000355	0.00362	CcSEcCtD
Rosuvastatin—Pruritus—Chlorambucil—ovarian cancer	0.000351	0.00358	CcSEcCtD
Rosuvastatin—Urticaria—Topotecan—ovarian cancer	0.000351	0.00358	CcSEcCtD
Rosuvastatin—Abdominal pain—Topotecan—ovarian cancer	0.000349	0.00356	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000344	0.00351	CcSEcCtD
Rosuvastatin—Urticaria—Melphalan—ovarian cancer	0.000344	0.0035	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Epirubicin—ovarian cancer	0.00034	0.00347	CcSEcCtD
Rosuvastatin—Diarrhoea—Chlorambucil—ovarian cancer	0.00034	0.00346	CcSEcCtD
Rosuvastatin—Paraesthesia—Vinorelbine—ovarian cancer	0.000339	0.00346	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000331	0.00338	CcSEcCtD
Rosuvastatin—Hypertonia—Doxorubicin—ovarian cancer	0.00033	0.00337	CcSEcCtD
Rosuvastatin—Jaundice—Docetaxel—ovarian cancer	0.000329	0.00336	CcSEcCtD
Rosuvastatin—Hepatic failure—Epirubicin—ovarian cancer	0.000329	0.00336	CcSEcCtD
Rosuvastatin—Hypersensitivity—Topotecan—ovarian cancer	0.000325	0.00332	CcSEcCtD
Rosuvastatin—Constipation—Vinorelbine—ovarian cancer	0.000323	0.0033	CcSEcCtD
Rosuvastatin—Pain—Vinorelbine—ovarian cancer	0.000323	0.0033	CcSEcCtD
Rosuvastatin—Renal failure acute—Epirubicin—ovarian cancer	0.00032	0.00327	CcSEcCtD
Rosuvastatin—Arrhythmia—Paclitaxel—ovarian cancer	0.00032	0.00326	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000319	0.00326	CcSEcCtD
Rosuvastatin—Hypersensitivity—Melphalan—ovarian cancer	0.000319	0.00325	CcSEcCtD
Rosuvastatin—Asthenia—Topotecan—ovarian cancer	0.000317	0.00323	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000315	0.00321	CcSEcCtD
Rosuvastatin—Mental disorder—Paclitaxel—ovarian cancer	0.000313	0.0032	CcSEcCtD
Rosuvastatin—Pruritus—Topotecan—ovarian cancer	0.000313	0.00319	CcSEcCtD
Rosuvastatin—Feeling abnormal—Vinorelbine—ovarian cancer	0.000311	0.00318	CcSEcCtD
Rosuvastatin—Asthenia—Melphalan—ovarian cancer	0.00031	0.00316	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000309	0.00315	CcSEcCtD
Rosuvastatin—Flatulence—Paclitaxel—ovarian cancer	0.000307	0.00313	CcSEcCtD
Rosuvastatin—Pruritus—Melphalan—ovarian cancer	0.000306	0.00312	CcSEcCtD
Rosuvastatin—Hepatic failure—Doxorubicin—ovarian cancer	0.000304	0.0031	CcSEcCtD
Rosuvastatin—Rhinitis—Docetaxel—ovarian cancer	0.000304	0.0031	CcSEcCtD
Rosuvastatin—ABCG2—lymph node—ovarian cancer	0.000304	0.00649	CbGeAlD
Rosuvastatin—Hepatitis—Docetaxel—ovarian cancer	0.000303	0.00309	CcSEcCtD
Rosuvastatin—Diarrhoea—Topotecan—ovarian cancer	0.000302	0.00308	CcSEcCtD
Rosuvastatin—Pharyngitis—Docetaxel—ovarian cancer	0.000301	0.00307	CcSEcCtD
Rosuvastatin—Urticaria—Vinorelbine—ovarian cancer	0.0003	0.00306	CcSEcCtD
Rosuvastatin—Abdominal pain—Vinorelbine—ovarian cancer	0.000299	0.00305	CcSEcCtD
Rosuvastatin—Renal failure acute—Doxorubicin—ovarian cancer	0.000296	0.00302	CcSEcCtD
Rosuvastatin—Diarrhoea—Melphalan—ovarian cancer	0.000296	0.00302	CcSEcCtD
Rosuvastatin—Nausea—Chlorambucil—ovarian cancer	0.000295	0.00301	CcSEcCtD
Rosuvastatin—Dizziness—Topotecan—ovarian cancer	0.000292	0.00298	CcSEcCtD
Rosuvastatin—Angioedema—Paclitaxel—ovarian cancer	0.000285	0.0029	CcSEcCtD
Rosuvastatin—Rash—Topotecan—ovarian cancer	0.000279	0.00284	CcSEcCtD
Rosuvastatin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000278	0.00284	CcSEcCtD
Rosuvastatin—Dermatitis—Topotecan—ovarian cancer	0.000278	0.00284	CcSEcCtD
Rosuvastatin—Headache—Topotecan—ovarian cancer	0.000277	0.00282	CcSEcCtD
Rosuvastatin—Rash—Melphalan—ovarian cancer	0.000273	0.00278	CcSEcCtD
Rosuvastatin—Dermatitis—Melphalan—ovarian cancer	0.000272	0.00278	CcSEcCtD
Rosuvastatin—Cough—Paclitaxel—ovarian cancer	0.000272	0.00277	CcSEcCtD
Rosuvastatin—Asthenia—Vinorelbine—ovarian cancer	0.000271	0.00276	CcSEcCtD
Rosuvastatin—Arrhythmia—Docetaxel—ovarian cancer	0.000271	0.00276	CcSEcCtD
Rosuvastatin—Pruritus—Vinorelbine—ovarian cancer	0.000267	0.00273	CcSEcCtD
Rosuvastatin—Breast disorder—Epirubicin—ovarian cancer	0.000267	0.00272	CcSEcCtD
Rosuvastatin—Mental disorder—Docetaxel—ovarian cancer	0.000266	0.00271	CcSEcCtD
Rosuvastatin—Arthralgia—Paclitaxel—ovarian cancer	0.000265	0.0027	CcSEcCtD
Rosuvastatin—Myalgia—Paclitaxel—ovarian cancer	0.000265	0.0027	CcSEcCtD
Rosuvastatin—Nausea—Topotecan—ovarian cancer	0.000262	0.00268	CcSEcCtD
Rosuvastatin—Muscular weakness—Epirubicin—ovarian cancer	0.000261	0.00266	CcSEcCtD
Rosuvastatin—Diarrhoea—Vinorelbine—ovarian cancer	0.000259	0.00264	CcSEcCtD
Rosuvastatin—Nausea—Melphalan—ovarian cancer	0.000257	0.00262	CcSEcCtD
Rosuvastatin—Confusional state—Paclitaxel—ovarian cancer	0.000256	0.00261	CcSEcCtD
Rosuvastatin—Influenza—Epirubicin—ovarian cancer	0.000256	0.00261	CcSEcCtD
Rosuvastatin—Infection—Paclitaxel—ovarian cancer	0.000253	0.00258	CcSEcCtD
Rosuvastatin—Pancreatitis—Epirubicin—ovarian cancer	0.000251	0.00255	CcSEcCtD
Rosuvastatin—Dizziness—Vinorelbine—ovarian cancer	0.00025	0.00255	CcSEcCtD
Rosuvastatin—Nervous system disorder—Paclitaxel—ovarian cancer	0.000249	0.00254	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000249	0.00254	CcSEcCtD
Rosuvastatin—Breast disorder—Doxorubicin—ovarian cancer	0.000247	0.00252	CcSEcCtD
Rosuvastatin—Bronchitis—Epirubicin—ovarian cancer	0.000246	0.00251	CcSEcCtD
Rosuvastatin—Muscular weakness—Doxorubicin—ovarian cancer	0.000241	0.00246	CcSEcCtD
Rosuvastatin—Rash—Vinorelbine—ovarian cancer	0.000238	0.00243	CcSEcCtD
Rosuvastatin—Dermatitis—Vinorelbine—ovarian cancer	0.000238	0.00243	CcSEcCtD
Rosuvastatin—Headache—Vinorelbine—ovarian cancer	0.000237	0.00241	CcSEcCtD
Rosuvastatin—Influenza—Doxorubicin—ovarian cancer	0.000236	0.00241	CcSEcCtD
Rosuvastatin—Pancreatitis—Doxorubicin—ovarian cancer	0.000232	0.00236	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000232	0.00236	CcSEcCtD
Rosuvastatin—Cough—Docetaxel—ovarian cancer	0.00023	0.00235	CcSEcCtD
Rosuvastatin—Insomnia—Paclitaxel—ovarian cancer	0.00023	0.00234	CcSEcCtD
Rosuvastatin—Paraesthesia—Paclitaxel—ovarian cancer	0.000228	0.00233	CcSEcCtD
Rosuvastatin—Bronchitis—Doxorubicin—ovarian cancer	0.000227	0.00232	CcSEcCtD
Rosuvastatin—Arthralgia—Docetaxel—ovarian cancer	0.000225	0.00229	CcSEcCtD
Rosuvastatin—Myalgia—Docetaxel—ovarian cancer	0.000225	0.00229	CcSEcCtD
Rosuvastatin—Nausea—Vinorelbine—ovarian cancer	0.000224	0.00229	CcSEcCtD
Rosuvastatin—Dyspepsia—Paclitaxel—ovarian cancer	0.000224	0.00228	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000223	0.00228	CcSEcCtD
Rosuvastatin—Jaundice—Epirubicin—ovarian cancer	0.000222	0.00226	CcSEcCtD
Rosuvastatin—Urinary tract infection—Epirubicin—ovarian cancer	0.000221	0.00226	CcSEcCtD
Rosuvastatin—Constipation—Paclitaxel—ovarian cancer	0.000217	0.00222	CcSEcCtD
Rosuvastatin—Pain—Paclitaxel—ovarian cancer	0.000217	0.00222	CcSEcCtD
Rosuvastatin—Haematuria—Epirubicin—ovarian cancer	0.000217	0.00222	CcSEcCtD
Rosuvastatin—Confusional state—Docetaxel—ovarian cancer	0.000217	0.00222	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000215	0.0022	CcSEcCtD
Rosuvastatin—Infection—Docetaxel—ovarian cancer	0.000214	0.00218	CcSEcCtD
Rosuvastatin—Sinusitis—Epirubicin—ovarian cancer	0.000214	0.00218	CcSEcCtD
Rosuvastatin—Nervous system disorder—Docetaxel—ovarian cancer	0.000211	0.00215	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000211	0.00215	CcSEcCtD
Rosuvastatin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000209	0.00214	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000208	0.00212	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000207	0.00211	CcSEcCtD
Rosuvastatin—Jaundice—Doxorubicin—ovarian cancer	0.000206	0.0021	CcSEcCtD
Rosuvastatin—Rhinitis—Epirubicin—ovarian cancer	0.000205	0.00209	CcSEcCtD
Rosuvastatin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000205	0.00209	CcSEcCtD
Rosuvastatin—Hepatitis—Epirubicin—ovarian cancer	0.000205	0.00209	CcSEcCtD
Rosuvastatin—Pharyngitis—Epirubicin—ovarian cancer	0.000203	0.00207	CcSEcCtD
Rosuvastatin—Urticaria—Paclitaxel—ovarian cancer	0.000202	0.00206	CcSEcCtD
Rosuvastatin—Haematuria—Doxorubicin—ovarian cancer	0.000201	0.00205	CcSEcCtD
Rosuvastatin—Abdominal pain—Paclitaxel—ovarian cancer	0.000201	0.00205	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000199	0.00203	CcSEcCtD
Rosuvastatin—Sinusitis—Doxorubicin—ovarian cancer	0.000198	0.00202	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000196	0.002	CcSEcCtD
Rosuvastatin—Insomnia—Docetaxel—ovarian cancer	0.000195	0.00199	CcSEcCtD
Rosuvastatin—Paraesthesia—Docetaxel—ovarian cancer	0.000193	0.00197	CcSEcCtD
Rosuvastatin—Rhinitis—Doxorubicin—ovarian cancer	0.00019	0.00193	CcSEcCtD
Rosuvastatin—Dyspepsia—Docetaxel—ovarian cancer	0.00019	0.00193	CcSEcCtD
Rosuvastatin—Hepatitis—Doxorubicin—ovarian cancer	0.000189	0.00193	CcSEcCtD
Rosuvastatin—Pharyngitis—Doxorubicin—ovarian cancer	0.000188	0.00192	CcSEcCtD
Rosuvastatin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000187	0.00191	CcSEcCtD
Rosuvastatin—Pain—Docetaxel—ovarian cancer	0.000184	0.00188	CcSEcCtD
Rosuvastatin—Constipation—Docetaxel—ovarian cancer	0.000184	0.00188	CcSEcCtD
Rosuvastatin—Arrhythmia—Epirubicin—ovarian cancer	0.000183	0.00186	CcSEcCtD
Rosuvastatin—Asthenia—Paclitaxel—ovarian cancer	0.000182	0.00186	CcSEcCtD
Rosuvastatin—Pruritus—Paclitaxel—ovarian cancer	0.00018	0.00183	CcSEcCtD
Rosuvastatin—Mental disorder—Epirubicin—ovarian cancer	0.000179	0.00183	CcSEcCtD
Rosuvastatin—Feeling abnormal—Docetaxel—ovarian cancer	0.000178	0.00181	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000176	0.0018	CcSEcCtD
Rosuvastatin—Flatulence—Epirubicin—ovarian cancer	0.000175	0.00179	CcSEcCtD
Rosuvastatin—Diarrhoea—Paclitaxel—ovarian cancer	0.000174	0.00177	CcSEcCtD
Rosuvastatin—Abdominal pain—Docetaxel—ovarian cancer	0.00017	0.00174	CcSEcCtD
Rosuvastatin—Arrhythmia—Doxorubicin—ovarian cancer	0.000169	0.00172	CcSEcCtD
Rosuvastatin—Dizziness—Paclitaxel—ovarian cancer	0.000168	0.00171	CcSEcCtD
Rosuvastatin—Mental disorder—Doxorubicin—ovarian cancer	0.000166	0.00169	CcSEcCtD
Rosuvastatin—Flatulence—Doxorubicin—ovarian cancer	0.000162	0.00166	CcSEcCtD
Rosuvastatin—Rash—Paclitaxel—ovarian cancer	0.00016	0.00163	CcSEcCtD
Rosuvastatin—Dermatitis—Paclitaxel—ovarian cancer	0.00016	0.00163	CcSEcCtD
Rosuvastatin—Headache—Paclitaxel—ovarian cancer	0.000159	0.00162	CcSEcCtD
Rosuvastatin—Hypersensitivity—Docetaxel—ovarian cancer	0.000159	0.00162	CcSEcCtD
Rosuvastatin—Cough—Epirubicin—ovarian cancer	0.000155	0.00158	CcSEcCtD
Rosuvastatin—Asthenia—Docetaxel—ovarian cancer	0.000155	0.00158	CcSEcCtD
Rosuvastatin—Pruritus—Docetaxel—ovarian cancer	0.000152	0.00155	CcSEcCtD
Rosuvastatin—Arthralgia—Epirubicin—ovarian cancer	0.000152	0.00155	CcSEcCtD
Rosuvastatin—Myalgia—Epirubicin—ovarian cancer	0.000152	0.00155	CcSEcCtD
Rosuvastatin—Nausea—Paclitaxel—ovarian cancer	0.000151	0.00154	CcSEcCtD
Rosuvastatin—Diarrhoea—Docetaxel—ovarian cancer	0.000147	0.0015	CcSEcCtD
Rosuvastatin—Confusional state—Epirubicin—ovarian cancer	0.000147	0.00149	CcSEcCtD
Rosuvastatin—Infection—Epirubicin—ovarian cancer	0.000144	0.00147	CcSEcCtD
Rosuvastatin—Cough—Doxorubicin—ovarian cancer	0.000144	0.00147	CcSEcCtD
Rosuvastatin—Nervous system disorder—Epirubicin—ovarian cancer	0.000143	0.00145	CcSEcCtD
Rosuvastatin—Dizziness—Docetaxel—ovarian cancer	0.000142	0.00145	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000142	0.00145	CcSEcCtD
Rosuvastatin—Arthralgia—Doxorubicin—ovarian cancer	0.00014	0.00143	CcSEcCtD
Rosuvastatin—Myalgia—Doxorubicin—ovarian cancer	0.00014	0.00143	CcSEcCtD
Rosuvastatin—Rash—Docetaxel—ovarian cancer	0.000136	0.00139	CcSEcCtD
Rosuvastatin—Dermatitis—Docetaxel—ovarian cancer	0.000136	0.00138	CcSEcCtD
Rosuvastatin—Confusional state—Doxorubicin—ovarian cancer	0.000136	0.00138	CcSEcCtD
Rosuvastatin—Headache—Docetaxel—ovarian cancer	0.000135	0.00138	CcSEcCtD
Rosuvastatin—Infection—Doxorubicin—ovarian cancer	0.000134	0.00136	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000132	0.00135	CcSEcCtD
Rosuvastatin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000132	0.00134	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000132	0.00134	CcSEcCtD
Rosuvastatin—Insomnia—Epirubicin—ovarian cancer	0.000131	0.00134	CcSEcCtD
Rosuvastatin—Paraesthesia—Epirubicin—ovarian cancer	0.00013	0.00133	CcSEcCtD
Rosuvastatin—Nausea—Docetaxel—ovarian cancer	0.000128	0.00131	CcSEcCtD
Rosuvastatin—Dyspepsia—Epirubicin—ovarian cancer	0.000128	0.0013	CcSEcCtD
Rosuvastatin—Pain—Epirubicin—ovarian cancer	0.000124	0.00127	CcSEcCtD
Rosuvastatin—Constipation—Epirubicin—ovarian cancer	0.000124	0.00127	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000123	0.00125	CcSEcCtD
Rosuvastatin—Insomnia—Doxorubicin—ovarian cancer	0.000122	0.00124	CcSEcCtD
Rosuvastatin—Paraesthesia—Doxorubicin—ovarian cancer	0.000121	0.00123	CcSEcCtD
Rosuvastatin—Feeling abnormal—Epirubicin—ovarian cancer	0.00012	0.00122	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000119	0.00121	CcSEcCtD
Rosuvastatin—Dyspepsia—Doxorubicin—ovarian cancer	0.000118	0.00121	CcSEcCtD
Rosuvastatin—Urticaria—Epirubicin—ovarian cancer	0.000115	0.00118	CcSEcCtD
Rosuvastatin—Pain—Doxorubicin—ovarian cancer	0.000115	0.00117	CcSEcCtD
Rosuvastatin—Constipation—Doxorubicin—ovarian cancer	0.000115	0.00117	CcSEcCtD
Rosuvastatin—Abdominal pain—Epirubicin—ovarian cancer	0.000115	0.00117	CcSEcCtD
Rosuvastatin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000111	0.00113	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00011	0.00112	CcSEcCtD
Rosuvastatin—Hypersensitivity—Epirubicin—ovarian cancer	0.000107	0.00109	CcSEcCtD
Rosuvastatin—Urticaria—Doxorubicin—ovarian cancer	0.000107	0.00109	CcSEcCtD
Rosuvastatin—Abdominal pain—Doxorubicin—ovarian cancer	0.000106	0.00108	CcSEcCtD
Rosuvastatin—Asthenia—Epirubicin—ovarian cancer	0.000104	0.00106	CcSEcCtD
Rosuvastatin—Pruritus—Epirubicin—ovarian cancer	0.000103	0.00105	CcSEcCtD
Rosuvastatin—Diarrhoea—Epirubicin—ovarian cancer	9.94e-05	0.00101	CcSEcCtD
Rosuvastatin—Hypersensitivity—Doxorubicin—ovarian cancer	9.91e-05	0.00101	CcSEcCtD
Rosuvastatin—Asthenia—Doxorubicin—ovarian cancer	9.65e-05	0.000984	CcSEcCtD
Rosuvastatin—Dizziness—Epirubicin—ovarian cancer	9.61e-05	0.00098	CcSEcCtD
Rosuvastatin—Pruritus—Doxorubicin—ovarian cancer	9.51e-05	0.00097	CcSEcCtD
Rosuvastatin—Diarrhoea—Doxorubicin—ovarian cancer	9.2e-05	0.000938	CcSEcCtD
Rosuvastatin—Rash—Epirubicin—ovarian cancer	9.16e-05	0.000934	CcSEcCtD
Rosuvastatin—Dermatitis—Epirubicin—ovarian cancer	9.15e-05	0.000934	CcSEcCtD
Rosuvastatin—Headache—Epirubicin—ovarian cancer	9.1e-05	0.000928	CcSEcCtD
Rosuvastatin—Dizziness—Doxorubicin—ovarian cancer	8.89e-05	0.000907	CcSEcCtD
Rosuvastatin—Nausea—Epirubicin—ovarian cancer	8.63e-05	0.00088	CcSEcCtD
Rosuvastatin—Rash—Doxorubicin—ovarian cancer	8.48e-05	0.000865	CcSEcCtD
Rosuvastatin—Dermatitis—Doxorubicin—ovarian cancer	8.47e-05	0.000864	CcSEcCtD
Rosuvastatin—Headache—Doxorubicin—ovarian cancer	8.42e-05	0.000859	CcSEcCtD
Rosuvastatin—Pitavastatin—ABCB1—ovarian cancer	8.14e-05	1	CrCbGaD
Rosuvastatin—Nausea—Doxorubicin—ovarian cancer	7.99e-05	0.000814	CcSEcCtD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.96e-05	0.000381	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—TYMS—ovarian cancer	1.95e-05	0.00038	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.94e-05	0.000377	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYTB—ovarian cancer	1.91e-05	0.000372	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.9e-05	0.00037	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	1.9e-05	0.00037	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—FASN—ovarian cancer	1.87e-05	0.000365	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—ABCB1—ovarian cancer	1.87e-05	0.000364	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.87e-05	0.000364	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.87e-05	0.000364	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PIK3CG—ovarian cancer	1.86e-05	0.000363	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PPP1CC—ovarian cancer	1.86e-05	0.000363	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—BRIP1—ovarian cancer	1.86e-05	0.000363	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.85e-05	0.000361	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—SLC5A5—ovarian cancer	1.84e-05	0.000359	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—TYMS—ovarian cancer	1.84e-05	0.000358	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PPP2R1A—ovarian cancer	1.81e-05	0.000352	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—VEGFA—ovarian cancer	1.79e-05	0.000349	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NME2—ovarian cancer	1.78e-05	0.000347	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—FASN—ovarian cancer	1.78e-05	0.000347	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—SLC2A1—ovarian cancer	1.78e-05	0.000347	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—NRAS—ovarian cancer	1.77e-05	0.000345	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.75e-05	0.000341	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.74e-05	0.00034	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYTB—ovarian cancer	1.74e-05	0.000339	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CYP1B1—ovarian cancer	1.71e-05	0.000333	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.7e-05	0.000332	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—MAPK3—ovarian cancer	1.7e-05	0.00033	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.69e-05	0.00033	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	1.68e-05	0.000328	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.67e-05	0.000326	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.67e-05	0.000325	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.67e-05	0.000325	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.66e-05	0.000323	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—FASN—ovarian cancer	1.65e-05	0.000321	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PIK3CD—ovarian cancer	1.64e-05	0.000319	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.63e-05	0.000317	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.62e-05	0.000316	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.62e-05	0.000316	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—MAPK1—ovarian cancer	1.61e-05	0.000314	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.57e-05	0.000307	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.57e-05	0.000306	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.57e-05	0.000305	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—ABCB1—ovarian cancer	1.56e-05	0.000304	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—TYMS—ovarian cancer	1.53e-05	0.000299	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—KRAS—ovarian cancer	1.52e-05	0.000297	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.52e-05	0.000297	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.52e-05	0.000297	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.51e-05	0.000295	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.51e-05	0.000293	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.5e-05	0.000293	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.5e-05	0.000293	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—CAV1—ovarian cancer	1.49e-05	0.00029	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.49e-05	0.00029	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—CAV1—ovarian cancer	1.48e-05	0.000288	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—YAP1—ovarian cancer	1.45e-05	0.000282	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.44e-05	0.00028	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—TERT—ovarian cancer	1.44e-05	0.00028	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.43e-05	0.000279	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.43e-05	0.000279	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PIK3CB—ovarian cancer	1.43e-05	0.000278	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.42e-05	0.000276	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.41e-05	0.000276	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—ABCB1—ovarian cancer	1.4e-05	0.000274	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—PIK3CA—ovarian cancer	1.4e-05	0.000273	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—TYMS—ovarian cancer	1.38e-05	0.000269	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CG—ovarian cancer	1.36e-05	0.000264	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.36e-05	0.000264	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TP53—ovarian cancer	1.35e-05	0.000264	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CG—ovarian cancer	1.35e-05	0.000263	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.33e-05	0.00026	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.33e-05	0.000259	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CAV1—ovarian cancer	1.33e-05	0.000259	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.31e-05	0.000256	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—HRAS—ovarian cancer	1.3e-05	0.000252	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	1.26e-05	0.000245	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—IL6ST—ovarian cancer	1.26e-05	0.000245	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—YAP1—ovarian cancer	1.25e-05	0.000243	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—ABCB1—ovarian cancer	1.24e-05	0.000241	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CAV1—ovarian cancer	1.24e-05	0.000241	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.23e-05	0.000241	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PTEN—ovarian cancer	1.23e-05	0.000241	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.23e-05	0.00024	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.22e-05	0.000237	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—TYMS—ovarian cancer	1.21e-05	0.000237	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—APC—ovarian cancer	1.21e-05	0.000236	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CD—ovarian cancer	1.19e-05	0.000232	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CD—ovarian cancer	1.18e-05	0.000231	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—FASN—ovarian cancer	1.18e-05	0.00023	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.18e-05	0.00023	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.16e-05	0.000226	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYTB—ovarian cancer	1.15e-05	0.000224	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—AKT1—ovarian cancer	1.14e-05	0.000223	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	1.13e-05	0.000219	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.12e-05	0.000219	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—YAP1—ovarian cancer	1.12e-05	0.000218	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CAV1—ovarian cancer	1.11e-05	0.000217	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.11e-05	0.000216	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.11e-05	0.000216	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	1.1e-05	0.000214	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.09e-05	0.000212	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.08e-05	0.00021	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PIK3CD—ovarian cancer	1.06e-05	0.000207	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.06e-05	0.000207	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CAV1—ovarian cancer	1.06e-05	0.000206	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CB—ovarian cancer	1.04e-05	0.000203	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CB—ovarian cancer	1.03e-05	0.000201	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—YAP1—ovarian cancer	1.02e-05	0.000199	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—FASN—ovarian cancer	1.02e-05	0.000198	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CG—ovarian cancer	1.01e-05	0.000197	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.01e-05	0.000197	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.01e-05	0.000197	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—BRIP1—ovarian cancer	1e-05	0.000196	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1e-05	0.000196	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1e-05	0.000196	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—SLC5A5—ovarian cancer	1e-05	0.000195	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	9.89e-06	0.000193	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CAV1—ovarian cancer	9.78e-06	0.000191	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.74e-06	0.00019	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—SLC2A1—ovarian cancer	9.66e-06	0.000188	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	9.62e-06	0.000188	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—IL2—ovarian cancer	9.54e-06	0.000186	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	9.54e-06	0.000186	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PTEN—ovarian cancer	9.48e-06	0.000185	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.46e-06	0.000184	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ERBB2—ovarian cancer	9.39e-06	0.000183	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MTOR—ovarian cancer	9.27e-06	0.000181	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PIK3CB—ovarian cancer	9.27e-06	0.000181	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CYP1B1—ovarian cancer	9.26e-06	0.000181	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—FASN—ovarian cancer	9.13e-06	0.000178	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SLC5A5—ovarian cancer	8.98e-06	0.000175	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTEN—ovarian cancer	8.93e-06	0.000174	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CG—ovarian cancer	8.91e-06	0.000174	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CD—ovarian cancer	8.9e-06	0.000174	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.88e-06	0.000173	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ABCB1—ovarian cancer	8.86e-06	0.000173	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PIK3CA—ovarian cancer	8.71e-06	0.00017	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—TYMS—ovarian cancer	8.7e-06	0.00017	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CDKN1B—ovarian cancer	8.69e-06	0.000169	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SLC2A1—ovarian cancer	8.67e-06	0.000169	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	8.62e-06	0.000168	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.49e-06	0.000166	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	8.46e-06	0.000165	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—FASN—ovarian cancer	8.32e-06	0.000162	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP1B1—ovarian cancer	8.31e-06	0.000162	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PPP2R1A—ovarian cancer	8.21e-06	0.00016	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CTNNB1—ovarian cancer	8.21e-06	0.00016	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SLC5A5—ovarian cancer	8.19e-06	0.00016	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.17e-06	0.000159	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—VEGFA—ovarian cancer	8.11e-06	0.000158	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—NRAS—ovarian cancer	8.01e-06	0.000156	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTEN—ovarian cancer	8.01e-06	0.000156	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SLC2A1—ovarian cancer	7.91e-06	0.000154	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CD—ovarian cancer	7.83e-06	0.000153	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CB—ovarian cancer	7.76e-06	0.000151	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.74e-06	0.000151	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—MAPK3—ovarian cancer	7.67e-06	0.00015	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ABCB1—ovarian cancer	7.63e-06	0.000149	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP1B1—ovarian cancer	7.58e-06	0.000148	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—TYMS—ovarian cancer	7.49e-06	0.000146	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTEN—ovarian cancer	7.45e-06	0.000145	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	7.37e-06	0.000144	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	7.37e-06	0.000144	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.34e-06	0.000143	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—MAPK1—ovarian cancer	7.3e-06	0.000142	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—STAT3—ovarian cancer	7.16e-06	0.00014	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—NRAS—ovarian cancer	7.14e-06	0.000139	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—AKT1—ovarian cancer	7.11e-06	0.000139	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CAV1—ovarian cancer	7.01e-06	0.000137	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—KRAS—ovarian cancer	6.89e-06	0.000134	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ABCB1—ovarian cancer	6.85e-06	0.000133	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MAPK3—ovarian cancer	6.84e-06	0.000133	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CB—ovarian cancer	6.83e-06	0.000133	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—YAP1—ovarian cancer	6.73e-06	0.000131	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—TYMS—ovarian cancer	6.72e-06	0.000131	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	6.72e-06	0.000131	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTEN—ovarian cancer	6.7e-06	0.000131	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.69e-06	0.00013	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	6.69e-06	0.00013	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MYC—ovarian cancer	6.65e-06	0.00013	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MAPK1—ovarian cancer	6.51e-06	0.000127	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—EGFR—ovarian cancer	6.51e-06	0.000127	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CG—ovarian cancer	6.38e-06	0.000124	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTEN—ovarian cancer	6.37e-06	0.000124	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CA—ovarian cancer	6.33e-06	0.000123	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CA—ovarian cancer	6.3e-06	0.000123	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ABCB1—ovarian cancer	6.24e-06	0.000122	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—KRAS—ovarian cancer	6.15e-06	0.00012	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—TYMS—ovarian cancer	6.13e-06	0.00012	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—ovarian cancer	6.13e-06	0.000119	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CAV1—ovarian cancer	6.04e-06	0.000118	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTEN—ovarian cancer	5.9e-06	0.000115	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—HRAS—ovarian cancer	5.86e-06	0.000114	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.77e-06	0.000112	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PIK3CA—ovarian cancer	5.65e-06	0.00011	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CD—ovarian cancer	5.61e-06	0.000109	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CG—ovarian cancer	5.5e-06	0.000107	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—FASN—ovarian cancer	5.49e-06	0.000107	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—AKT1—ovarian cancer	5.47e-06	0.000107	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CAV1—ovarian cancer	5.42e-06	0.000106	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.4e-06	0.000105	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	5.26e-06	0.000102	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HRAS—ovarian cancer	5.23e-06	0.000102	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.22e-06	0.000102	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.18e-06	0.000101	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—AKT1—ovarian cancer	5.17e-06	0.000101	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—AKT1—ovarian cancer	5.14e-06	0.0001	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—IL6—ovarian cancer	5e-06	9.75e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5e-06	9.75e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CAV1—ovarian cancer	4.94e-06	9.63e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CG—ovarian cancer	4.94e-06	9.62e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4.89e-06	9.54e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CD—ovarian cancer	4.83e-06	9.42e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CA—ovarian cancer	4.73e-06	9.22e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.72e-06	9.2e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—AKT1—ovarian cancer	4.61e-06	8.99e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.5e-06	8.77e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	4.5e-06	8.76e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.43e-06	8.64e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.34e-06	8.46e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—AKT1—ovarian cancer	4.29e-06	8.37e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTEN—ovarian cancer	4.23e-06	8.24e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CB—ovarian cancer	4.21e-06	8.21e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CA—ovarian cancer	4.16e-06	8.11e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.12e-06	8.03e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—TYMS—ovarian cancer	4.04e-06	7.88e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.96e-06	7.71e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—AKT1—ovarian cancer	3.86e-06	7.53e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.78e-06	7.37e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—AKT1—ovarian cancer	3.67e-06	7.16e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTEN—ovarian cancer	3.64e-06	7.1e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.45e-06	6.72e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—AKT1—ovarian cancer	3.4e-06	6.63e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTEN—ovarian cancer	3.27e-06	6.37e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CAV1—ovarian cancer	3.26e-06	6.35e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.98e-06	5.81e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTEN—ovarian cancer	2.98e-06	5.81e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.97e-06	5.79e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.61e-06	5.09e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CA—ovarian cancer	2.57e-06	5.01e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—AKT1—ovarian cancer	2.44e-06	4.75e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.31e-06	4.49e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.27e-06	4.43e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.1e-06	4.1e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—AKT1—ovarian cancer	2.1e-06	4.09e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTEN—ovarian cancer	1.97e-06	3.83e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—AKT1—ovarian cancer	1.88e-06	3.67e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—AKT1—ovarian cancer	1.72e-06	3.35e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.39e-06	2.7e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—AKT1—ovarian cancer	1.13e-06	2.21e-05	CbGpPWpGaD
